GC Genome

GC Genome Quick Ratio

The Quick Ratio (Acid Test) of GC Genome (340450.KQ) as of Oct 24, 2026 is 17.57. In the previous year, Quick Ratio (Acid Test) was 3.49 — a change of 403.34% (higher).

Quick Ratio

17.57

YoY

403.34%

Last updated:

Quick Ratio (Acid Test) of GC Genome is 2025 17.57 . Quick Ratio (Acid Test) of GC Genome was 2024 3.49 . It decreases by 403.34% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GC Genome Stock analysis

What does GC Genome do? GC Genome Corp provides prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, and precision diagnosis genetic testing for rare diseases. The company also offers health checkup test services. These services are sold to healthcare providers, hospitals, and clinics seeking advanced diagnostic solutions. The firm generates revenue through direct contracts with medical institutions for these specialized genetic testing packages. The company's core products include clinical genome analysis services tailored for specific medical scenarios. Prenatal and newborn screening targets expectant parents and pediatric care facilities, while cancer and rare disease diagnostics serve oncology and specialized medical departments. Health checkup tests are marketed to wellness centers and preventive care programs. GC Genome Corp's business model relies on recurring contracts with healthcare institutions for ongoing genetic testing needs. The firm's services are positioned as premium diagnostic tools for high-value medical applications, attracting clients focused on precision medicine and early disease detection. GC Genome is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GC Genome stock

Quick Ratio (Acid Test) of GC Genome is 17.57 in 2025.

Quick Ratio (Acid Test) of GC Genome changed from 3.49 to 17.57, representing a 403.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) GC Genome since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s GC Genome with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — GC Genome

All Key Metrics — GC Genome